<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="preparation" /><meta name="keywords" content="Pyrazinamide" /><meta name="IX" content="Pyrazinamide" /><title>Pyrazinamide: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP3614-pyrazinamide-non-proprietary.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP3614-pyrazinamide-non-proprietary.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP3614-pyrazinamide-non-proprietary.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 08 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP3253-infections.htm">5 Infections</a> &gt; <a href="PHP3256-antibacterial-drugs.htm">5.1 Antibacterial drugs</a> &gt; <a href="PHP3588-antituberculosis-drugs.htm">5.1.9 Antituberculosis drugs</a> &gt; <a href="PHP3612-pyrazinamide.htm">PYRAZINAMIDE</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP3608-isoniazid.htm" title="Previous: ISONIAZID">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP3616-rifabutin.htm" title="Next: RIFABUTIN">Next page</a> ►</div></div></div></div><div id="p1"><div id="sideBar"><h2>See Also</h2><ul><li><h3>AHFS Drug Information</h3></li><li><a href="http://www.medicinescomplete.com/mc/ahfs/2010/a382402.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>AHFS Drug Information</strong> &gt; Anti-infective Agents 8:00 &gt; Antimycobacterials 8:16 &gt; Antituberculosis Agents 8:16.04</p></div></li></ul><ul><li><h3>Stockley's Interaction Alerts</h3></li><li><a href="http://www.medicinescomplete.com/mc/alerts/2010/7568-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Pyrazinamide</a><div class="breadcrumb"><p><strong>Stockley's Interaction Alerts</strong> &gt; Interactants: P &gt; Interactions of Pyrazinamide</p></div></li></ul><ul><li><h3>British National Formulary (2)</h3></li><li><a href="PHP3588-antituberculosis-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.1.9 Antituberculosis drugs</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs</p></div></li><li><a href="PHP3612-pyrazinamide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">PYRAZINAMIDE</a><div class="breadcrumb"><p><strong>British National Formulary</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs</p></div></li></ul><ul><li><h3>BNF for Children (4)</h3></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12840-antituberculosis-drugs.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">5.1.9 Antituberculosis drugs</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12855-pyrazinamide.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">PYRAZINAMIDE</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs</p></div></li><li><a href="http://www.medicinescomplete.com/mc/bnfc/2011/PHP12857-pyrazinamide-non-proprietary.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>BNF for Children</strong> &gt; 5 Infections &gt; 5.1 Antibacterial drugs &gt; 5.1.9 Antituberculosis drugs &gt; PYRAZINAMIDE</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22pyrazinamide%22%22pyrazinamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (4)</a></li></ul><ul><li><h3>Clarke's Analysis of Drugs and Poisons</h3></li><li><a href="http://www.medicinescomplete.com/mc/clarke/2010/CLK1426.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>Clarke's Analysis of Drugs and Poisons</strong> &gt; Monographs &gt; Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Stability-Indicating HPLC Methods for Drug Analysis</h3></li><li><a href="http://www.medicinescomplete.com/mc/hplc/2008/ch0015s0523.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>Stability-Indicating HPLC Methods for Drug Analysis</strong> &gt; Monographs &gt; P</p></div></li></ul><ul><li><h3>Kucers' the Use of Antibiotics (7)</h3></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/pyrazinamide_description.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Description</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 112 Pyrazinamide</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/pyrazinamide_antimicrobial_activity.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Antimicrobial activity</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 112 Pyrazinamide</p></div></li><li><a href="http://www.medicinescomplete.com/mc/kucers/2010/pyrazinamide_mechanism_of_drug_action.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Mechanism of drug action</a><div class="breadcrumb"><p><strong>Kucers' the Use of Antibiotics</strong> &gt; Antibiotics &gt; Anti-Tuberculous Drugs &gt; 112 Pyrazinamide</p></div></li><li><a class="seeAll" href="http://www.medicinescomplete.com/mc/related.htm?q=%22pyrazinamide%22%22pyrazinamide%22" onclick="pageTracker._trackEvent('Related-Topic','Related-See-All');">see all (7)</a></li></ul><ul><li><h3>Martindale: The Complete Drug Reference</h3></li><li><a href="http://www.medicinescomplete.com/mc/martindale/2009/7568-a.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>Martindale: The Complete Drug Reference</strong> &gt; Drugs and Ancillary Substances &gt; By therapeutic use &gt; Antibacterials &gt; Drug Monographs</p></div></li></ul><ul><li><h3>The Merck Index</h3></li><li><a href="http://www.medicinescomplete.com/mc/merck/2010/07956.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>The Merck Index</strong> &gt; Monographs &gt; P &gt; PY</p></div></li></ul><ul><li><h3>Remington: The Science and Practice of Pharmacy</h3></li><li><a href="http://www.medicinescomplete.com/mc/rem/2012/mono-P156.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>Remington: The Science and Practice of Pharmacy</strong> &gt; Part 3: Pharmaceutical and Medicinal Agents &gt; P</p></div></li></ul><ul><li><h3>Stockley's Drug Interactions</h3></li><li><a href="http://www.medicinescomplete.com/mc/stockley/2010/int-E2E0E6E3E0R0D104.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Interactions of Pyrazinamide</a><div class="breadcrumb"><p><strong>Stockley's Drug Interactions</strong> &gt; Interactants, Alphabetically &gt; P</p></div></li></ul><ul><li><h3>Drug Administration via Enteral Feeding Tubes</h3></li><li><a href="http://www.medicinescomplete.com/mc/tubes/2010/c318.htm" onclick="pageTracker._trackEvent('Related-Topic','Related-Click');">Pyrazinamide</a><div class="breadcrumb"><p><strong>Drug Administration via Enteral Feeding Tubes</strong> &gt; Handbook of Drug Administration via Enteral Feeding Tubes &gt; Monographs &gt; P</p></div></li></ul><script type="text/javascript" src="scripts/sidebar.js"></script></div><div id="pB"><h1>PYRAZINAMIDE</h1><?highlighter on?><div id="pC" class="jN"><div class="cL"><div class="cE"><h3 class="cO">Additional information</h3> <p class="cT"> interactions (<a href="bnf_int192-pyrazinamide.htm">Pyrazinamide</a>).</p></div></div><div class="cL"><div class="cE"><h2 class="cN">Indications </h2> <p class="cT">tuberculosis in combination with other drugs [unlicensed]</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Cautions </h2> <p class="cT">see Monitoring in <a title="BNF:target-block: Antituberculous drugs and liver monitoring" href="PHP3588-antituberculosis-drugs.htm#PHP3593">notes above</a>; also diabetes; gout (avoid in acute attack); <strong>interactions:</strong> Appendix 1 (pyrazinamide)</p></div> <div id="PHP3613" class="cG"><div class="cE"><h3 class="cT">Hepatic disorders</h3> <p class="cT">Patients or their carers should be told how to recognise signs of liver disorder, and advised to discontinue treatment and seek immediate medical attention if symptoms such as persistent nausea, vomiting, malaise or jaundice develop</p></div></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Contra-indications </h2> <p class="cT">acute porphyria (<a title=" Acute porphyrias" href="PHP6363-acute-porphyrias.htm">section 9.8.2</a>)</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Hepatic impairment </h2> <p class="cT">monitor hepatic function—idiosyncratic hepatotoxicity more common; avoid in severe hepatic impairment; see also Hepatic Disorders above</p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Renal impairment </h2> <p class="cT">monitor for gout; 25–30 mg/kg 3 times a week if eGFR less than 30 mL/minute/1.73 m<sup>2</sup></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Pregnancy </h2> <p class="cT">manufacturer advises use only if potential benefit outweighs risk; see also <a title="BNF:target-block: pregnancy and breast-feeding - antituberculous drugs" href="PHP3588-antituberculosis-drugs.htm#PHP3590">Pregnancy</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Breast-feeding </h2> <p class="cT">amount too small to be harmful; see also <a title="BNF:target-block: Breast-feeding - antituberculosis drugs" href="PHP3588-antituberculosis-drugs.htm#PHP3591">Breast-feeding</a></p></div> </div> <div class="cL"><div class="cE"><h2 class="cN">Side-effects </h2> <p class="cT">hepatotoxicity including fever, anorexia, hepatomegaly, splenomegaly, jaundice, liver failure; nausea, vomiting, flushing, dysuria, arthralgia, sideroblastic anaemia, thrombocytopenia, rash and occasionally photosensitivity</p></div> </div> <div class="cL"><h2 class="cM">Dose</h2><div class="cR"><ul><li><p>See <a title="BNF:sub-section: Antituberculosis drugs" href="PHP3588-antituberculosis-drugs.htm">notes above</a></p></li> </ul></div></div> </div><div id="pS"><p>Sub-sections</p><div id="PHP3614-pyrazinamide-non-proprietary" style="margin: 0 0 0 20px;"><h1 class="title">Pyrazinamide <span>(Non-proprietary)</span><span> <img src="images/pom_l.png" alt="Prescription only medicine" /></span></h1><div class="cU"><p><strong>Tablets</strong>, scored, pyrazinamide 500 mg. Label: 8</p><p class="cR">Available from <a title="BNF:appendix: Special-order Manufacturers" href="PHP10403-special-order-manufacturers.htm">‘special order’ manufacturers or specialist-importing companies</a></p></div></div><ul class="jT"><li><a href="PHP3615-pyrazinamide-formulations-unlicensed.htm#PHP3615-pyrazinamide-formulations-unlicensed" title="Pyrazinamide formulations (unlicensed)">Pyrazinamide formulations (unlicensed)</a></li></ul></div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP3608-isoniazid.htm">Previous: ISONIAZID</a> | <a class="top" href="PHP3614-pyrazinamide-non-proprietary.htm#">Top</a> | <a accesskey="]" href="PHP3616-rifabutin.htm">Next: RIFABUTIN</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>